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Abstract 
Metageria is a generalized form of acrogeria belonging to the group of premature aging syndromes and is characterized 
by loss of subcutaneous fat, thinning of the dermis, multiple teleangiectasias nd mottled hyperpigmentation. The skin 
changes present suggest hat an altered formation of extracellular matrix might be involved in the pathogenesis of this 
disease. 
Fibroblasts obtained from the skin of a patient with this disease revealed a marked reduction of type I collagen 
expression to about 20% of control evels both at the mRNA and protein level. In addition decreased decorin but unchanged 
type IV collagen and fibronectin mRNA levels were found. Similar although less pronounced changes were observed in 
fibroblasts obtained from the sister of this patient showing skin changes compatible with acrogeria. 
To further analyze the deficient expression of type I collagen run on analysis was performed revealing a decrease of 
transcription of type I collagen. Incubation of the cells with transforming rowth factor-t, a strong inducer of type I 
collagen and extracellular matrix formation, restored type I collagen expression both at the mRNA and protein level to 
amounts comparable with normal skin fibroblasts. 
These results are consistent with a defect in type I collagen transcription that is readily reversed after incubation with 
transforming rowth factor /3. The deficient synthesis of type I collagen and decorin by dermal fibroblasts might thus 
contribute to an altered formation of the extracellular matrix resulting in the poikilodermic skin changes observed in this 
patient. 
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1. Introduction 
The premature aging syndromes consist of proge- 
ria, acrogeria, metageria, Werner syndrome and 
* Corresponding author. Fax: + 49 (0)221 4784549. 
progeroid like syndromes as the Wiedemann- 
Rautenstrauch syndrome [1,2]. These diseases repre- 
sent rare disorders which simulate but also differ 
from the normal aging process. The biochemical and 
molecular abnormalities underlying these disorders 
are poorly understood. Recently a study on the posi- 
tional cloning of the Werner's syndrome gene re- 
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vealed a mutated putative helicase as a molecule 
which could be involved in this complex disorder [3]. 
Also to date no classification exists that allows to 
characterize a patient with a premature aging syn- 
drome according to specific metabolic errors. 
The clinical appearance of these patients with loss 
of subcutaneous fat, poikilodermic skin changes, 
marfanoid or dwarf like stature suggests, that an 
altered regulation of ECM synthesis and architecture 
may play a major role in the pathogenesis of these 
syndromes. The distinct constituents of the extracellu- 
lar matrix include collagens, elastic fibers, non-col- 
lagenous glycoproteins and proteoglycans. Type I 
collagen is the most abundant collagen species in 
many soft tissues and accounts for about 80% of all 
skin collagen. Collagen production is regulated by a 
number of biological signals affecting the transcrip- 
tional, translational nd posttranslational level of the 
synthesis of the mature collagen molecule which 
have been shown to be involved in several diseases 
as, e.g. in Ehlers-Danlos yndrome or osteogenesis 
imperfecta. 
The major small proteoglycan synthesized by hu- 
man dermal fibroblasts is decorin. Decorin derives its 
name from the observation that it binds through its 
core protein to the surface of collagen fibrils. Further- 
more a role in collagen fibrillogenesis, growth factor 
binding and the formation of the extracellular matrix 
has been ascribed to this protein [4]. Through its 
capacity to bind transforming rowth factor-/3 and 
block its biologic effect in vitro a role of decorin in 
the regulation of growth factor activity has been 
proposed [5]. 
We describe a patient showing the characteristic 
skin changes of metageria, i.e. generalized loss of 
subcutaneous fat, mottled hyperpigmentation, gener- 
alized teleangiectasia, and a bird like facies [6]. In 
addition an insulin-dependent diabetes mellitus was 
present. This syndrome has been described by Gilkes 
et al. [1] in order to adequately describe two patients 
that did not fit into the diagnostic riteria of acroge- 
ria, pangeria (Werner's syndrome) and progeria 
(Hutchinson-guilford syndrome). Fibroblasts obtained 
from the affected skin of our patient revealed a 
markedly decreased expression of type I collagen and 
decorin. It is suggested that the deficient expression 
of these extracellular matrix proteins might be in- 
volved in the pathogenesis of this disease. 
2. Material and methods 
2.1. Patients 
The male patient of caucasian ancestry had been 
described previously [6] and is now 25 years of age 
(50 kg, 171 cm). Major clinical features include 
generalized loss of subcutaneous fat and a thinning of 
the dermis. Multiple teleangiectasias are present, most 
pronounced on the upper back, as well as a general- 
ized mottled hyperpigmentation. Scalp hair is fine 
and thin. The patient has a bird-like face, clubbing is 
present and a onychodystrophy of D1 bilaterally. 
Phimose was present and treated by circumcision. On 
physical examination a grade 2 /6  murmur was pre- 
sent along the left sternal border, an insulin pump 
was present on the left lower abdomen. Insulin-de- 
pendent diabetes mellitus was diagnosed when the 
patient was 17 years of age. The opthalmologic ex- 
amination revealed hyperopia nd vitrous body ad- 
herence of the right eye. The endocrinologic exami- 
nation showed testosterone, FSH, LH levels within 
normal limits. A type IV hypertriglyceridemia w s 
present with triglycerides 405 mg/dl  and cholesterol 
247 mg/dl.  Similar skin changes however estricted 
to the hands and feet were present in the sister (19 
years old) and the mother of the patient and were 
reported also for the grandmother of the patient lead- 
ing to the diagnosis of acrogeria. Maximum age in 
the family reached 55, due to cardiovascular diseases 
as a consequence of advanced atherosclerosis. 
2.2. Fibroblast cultures 
Fibroblast cultures were established from involved 
skin of the back of the patient and the forearm of his 
sister as described previously [7]. Control cultures 
were initiated from age matched healthy subjects. 
The cells were separately grown to confluency in 
monolayer cultures in DMEM, supplemented with 
10% fetal calf serum (FCS), 50 /xg/ml ascorbate, 
300 /xg/ml glutamine, 50 /zg/ml streptomycin and 
400 U/ml  penicillin. Transforming growth factor/31 
(8 ng/ml) was obtained from Boehringer, Mannheim, 
Gremany. 
2.3. Isolation and analysis of total RNA: 
For the determination f the mRNA levels, fibro- 
blasts were cultured in 10 cm tissue culture dishes as 
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described above. Total RNA was isolated according 
to established procedures [8] by ultracentrifugation 
through CsCI. For northern blot analysis, total RNA 
was resolved by gel electrophoresis in 1% agarose 
under denaturing conditions and thereafter t ansferred 
to nylon filters (genescreen, DuPont, USA) as previ- 
ously described [8]. As a control for equal loading 
and integrity of RNA, the membranes were stained 
with methylene blue, 0.04% in 0.2 M NaAc (pH 5.2). 
Following prehybridization (50% formamide, 2 x 
SSC, 0.1% SDS, 250 txg/ml salmon sperm), hy- 
bridization was carried out in the same solvent using 
32p-labelled cDNA. The following human sequence 
specific cDNA probes were used for the different 
hybridizations: a 1.2 kb EcoRI fragment of the clone 
HF 677 coding for the a 1 (I) chain [9]; a 1.78 kb 
human cDNA for decorin [10], a 1.4 kb human 
cDNA for Type IV collagen [11], a 900 bp human 
cDNA for fibronectin [12] and a 1.3 kb cDNA for 
GAPDH (kindly provided by Dr. J. Uitto). After 
hybridization filters were washed under stringent 
conditions and exposed at -80°C to a radiosensitive 
film (Kodak, X-Omat AR). Before rehybridization 
filters were stripped in 0.1 X SSC, I%SDS for 20 
min at 100°C. Quantification was achieved by densi- 
tometrical scanning of the autoradiograms. Values are 
expressed as percent of untreated controls. 
2.5. Protein analysis 
The determination f collagen type I was done by 
a modification of the method of Sykes et al. [15]. 
Fibroblasts were seeded in six well plates (100000 
cells/well) in DMEM supplemented with 10% FCS. 
After cultures reached confluence, the medium was 
removed and the monolayer was rinsed twice with 
PBS. In each well 3 ml DMEM supplemented with 
10% FCS and /3-aminoproprionitrile (100 /xg/ml) 
were added. Immediately afterwards the cultures were 
pulsed with L-[U-14C]proline, 1 tzCi/wel l ,  
(Amersham) for 48 h. Thereafter the medium was 
removed, transferred to a new tube and 1 ml of a 
pepsin solution (2 mg/ml  0.5 M acetic acid) was 
added for 16 h at 20°C. The clear solution was 
2.4. Run on analysis 
Preparation of nuclei, run on transcription and 
hybridization were performed as described in [13]. 
Briefly, fibroblast nuclei were prepared according to 
Marzluff and Huang [14] by ultracentrifugation 
through 2.4 M sucrose. To be certain that comparable 
amounts of nuclei were present per aliquot, DNA 
content in lysed aliquots were determined. 40 /xl of 
nuclei per reaction were used in a total volume of 
100 /xl. Transcripts were labeled with 1.85 MBq of 
(o l -32p)-UTP (Amersham, 3000 Ci/mmol). 
1 × l07 cpm of reactions which had yielded com- 
parable total counts were hybridized to slot-blotted 
cDNA (1 /×g/slot of Hf677 and FN771) for 36 h in 
5 X SSC, 1% sodium laurylsarcosine at 65°C and 
washed as described. Signal intensities were deter- 
mined densitometrically and values were normalized 
to GAPDH signals. 
Fig. 1. Subconfluent culture of metageria skin fibroblasts (a). 
Note the polygonal aspect, the cytoplasm with granular appear- 
ance when compared to normal fibroblasts (b). 
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neutralized with 2.5 N NaOH. Polyacrylamide gel 
electrophoresis of precipitated proteins was per- 
formed using a gradient gel (5-15% acrylamide con- 
centration). The determination f [ 14C]proline-labeled 
collagen type I was performed using the phosphoi- 
mager R (Molecular Dynamics). 
3. Results 
Fibroblasts cultured both from the patient with 
metageria and to a lesser extent from his sister show- 
ing skin signs compatible with acrogeria showed 
abnormal morphology revealing a polygonal shape 
and granular cytoplasm and slightly reduced growth 
activity (Fig. 1). Cultured fibroblasts were examined 
for the mRNA expression of a l(I) procollagen by 
northern blot analysis revealing a marked decrease 
when compared to control fibroblasts (Fig. 2, 3,6; 
Table 1) after correlation with GAPDH mRNA. Fi- 
broblasts obtained from the sister displayed a less 
marked reduction of collagen synthesis in comparison 
to control levels (Table 1, Fig. 3). Electrophoretic 
mobility of the transcripts of 4.8 and 5.8 kb as 
determined by an RNA size marker was identical in 
patients and control, indicating that there was no 
Table 1 
Steady-state l vel of different mRNAs (in % of control) in 
metageria (patient) and acrogeria (sister) fibroblasts, values in 
normal fibroblast cultures normalized to GAPDH were set arbi- 
trarily at 100% 
Sister Patient 
Decorin 35.6%+2.1% 10.8%+ 1.0% 
ot I(IV) collagen 79.5% _ 14% 75.6% + 8.7% 
Fibronectin 101% _+ 4.1% 83.7% _ 8.3% 
The relative amounts of specific mRNAs were quantified by 
densitometric scanning_S.D, of three independent determina- 
tions. 
123 
18S - decor in  
28S - ~1(I )  co l lagen 
1 2 3 4 
28S - c~l(IV) co l lagen 
a l  (I) collagen 
~ ~,g l lD  * ~  GAPDH 
Fig. 2. Collagen type I expression in cultured fibroblasts of the 
patient with metageria and stimulation by TGF-/3. Confluent cells 
of control fibroblasts (lanes 1, 2) and patient (lanes 3, 4) were 
incubated with (lanes 2, 4) or without TGF-/3 for 48 h (lanes 1, 
3). Note the marked reduction of type I collagen mRNA expres- 
sion in the patient and its induction by TGF-/3. Densitometric 
results are shown in Fig. 6. 
f ibronect in 
28S - 
18S - ~!~!iii?~iiiiiiii~ili!~iiiii!!!i 
GAPDH 
Fig. 3. Northern blot analysis of 5 /xg total RNA obtained from 
fibroblasts of an age matched control (lane 1), the patient (lane 2) 
and his sister (lane 3); after hybridization for decorin, a l(I) 
collagen, c~ 1 type IV collagen and fibronectin, note the marked 
decrease of eel(I) collagen and decorin mRNA in the patients 
fibroblasts being less pronounced in his sister, whereas no major 
difference is noted with fibronectin and type IV collagen mRNA; 
hybridization with a cDNA specific for GAPDH as a control for 
the amount of total RNA applied is also shown. 
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Fig. 4. Transcriptional ctivity of the c~ 1(I) collagen, fibronectin 
and GAPDH genes was assessed by run-on transcription analysis 
in isolated fibroblast nuclei from the skin of the patient, his sister 
and an unrelated control. After subtraction of filter specific 
backround and normalization of signal intensities to those of 
GAPDH, relative transcriptional ctivities were calculated and 
are shown in Table 2. 
I 2 3 4 5 6 7 8 
/ i ]  ~' ~ i ~i~i~!~i:!!~!i!ii~i~ i : , =!  ~ ! ~ii!: ii/i 4i!!~ i 
+- cd collagen type I
+- ct2 collagen type I
Fig. 5. Synthesis of collagen type I protein in fibroblasts from the 
patient with metageria, control fibroblasts and stimulation by 
TGF-/3. Confluent control fibroblasts (lanes 1-4) and fibroblasts 
from the patient (lanes 5-8) were incubated in duplicates with 
(lanes 3, 4 and 7, 8) or without TGF-/3 for 48 h (lanes 1, 2 and 5, 
6). Note the marked reduction of both c~-chains of type I collagen 
in the patient and their induction by TGF-/3 as determined by two 
independent experiments. Densitometric results are shown in Fig. 
7, values in normal fibroblast cultures were set arbitrarily to 
100%. 
major difference in the transcript size. A similar 
dramatic decrease of specific mRNA was observed 
when the same filters were hybridized with the cDNA 
for decorin, whereas largely unchanged levels were 
observed for c~ I(IV) collagen and fibronectin using 
hybridization of GAPDH as an internal control for 
even RNA loading (see Table 1, Fig. 3). 
To determine further the mechanism responsible 
for the reduced steady state levels of ce 1(I) collagen 
mRNA, nuclear run on transcription studies were 
performed. The results are shown in Fig. 4, revealing 
a marked downregulation of transcription to about 
40% of control values, whereas levels of fibronectin 
are unaffected (Table 2). This indicates that the defi- 
cient expression of type I collagen leading to mRNA 
steady state levels of 20% of control is to a consider- 
able extent due to impaired transcriptional ctivity of 
this gene. 
In addition cultured fibroblast were examined for 
the biosynthesis of type I collagen by metabolic 
labeling with L-[U-laC]proline. As expected, due to 
the reduced c~ 1(I) collagen mRNA levels a reduction 
Table 2 
Densitometric data of run-on transcription analysis normalized to 
GAPDH, values in normal fibroblast cultures were set arbitrarily 
at 100% 
oL l(I)Collagen Fibronectin 
Control 100% 100% 
Sister 98% 108% 
Patient 37% 88% 
of collagen synthesis to about 40% of control levels 
was seen (see Figs. 5 and 6). However, no abnormal 
migration of bands representing both collagen chains 
was observed in polyacrylamide gel electrophoresis 
(Fig. 5). 
As TGF-/3 has been previously shown to be a 
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Fig. 6. Densitometric data of the Northern blot analysis of 
collagen type I expression shown in Fig. 2. GAPDH levels served 
as a standard to determine the relative amounts of type I collagen 
specific mRNA (n = 3; ±S.D.). Values in normal fibroblast 
cultures were set arbitrarily at 100%. 
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Fig. 7. Densitometric data of SDS PAGE analysis of Collagen 
type I protein synthesis performed in duplicate as shown in Fig. 5 
(n = 4; + SD). 
potent inducer of type I collagen expression [16], it 
was investigated whether TGF-/3 could reverse the 
deficient expression of type I collagen in this patients 
fibroblast strain. Fibroblasts were incubated for 48 h 
with TGF-fl (8 ng/ml) and analysed for mRNA 
expression as well as protein synthesis. At higher 
passage number (e.g. 8th-10th) where these experi- 
ments were performed, decorin mRNA expression 
had returned to normal levels in untreated cultures 
and incubation with TGF-/3 decreased decorin mRNA 
levels as previously described [17] (not shown). How- 
ever, type I collagen expression remained eficient 
and synthesis was strongly stimulated bringing pro- 
duction to the level of normal unstimulated control 
fibroblasts (Figs. 2 and 5-7) thus reversing the defi- 
cient type I collagen expression. 
4. Discussion 
To date patients suspected to have a premature 
aging syndrome can only be diagnosed according to 
criteria such as skin morphology, age of onset, pres- 
ence of metabolic abnormalities (accelerated athero- 
sclerosis, diabetes mellitus, hypogonadism) and 
stature. According to these criteria the patient de- 
scribed in this case report can be diagnosed as 
metageria, a syndrome described by Gilkes in 1974 
[1]. The symptoms that differentiate metageria from 
acrogeria include generalization of skin changes and 
loss of the subcutaneous fat together with the pres- 
ence of diabetes mellitus and early atherosclerosis. 
Criteria which were all present in this patient. How- 
ever, it is not clear whether metageria is a syndrome 
of its own or simply a more severe form of acrogeria 
[6,18]. 
Fibroblasts obtained from affected skin revealed a
marked reduction of the expression of two major 
constituents of the extracellular matrix of the skin, 
i.e. a l (I) collagen and decor~n. Interestingly, a
similar although much less pronounced reduction in 
a l (I) collagen and decorin expression was also 
observed in fibroblasts obtained from the sister of the 
patient fulfilling the criteria for the diagnosis of 
acrogeria. This may correspond to the less pro- 
nounced poikilodermic skin changes, which were re- 
stricted to the hands and feet and might also explain 
why in a previous tudy no major alteration of type I 
collagen synthesis was found [19] in one acrogeria 
patient. The occurrence of acrogeria nd metageria n
siblings as well as a similar defect in the expression 
of decorin and type I collagen however might indi- 
cate that acrogeria nd metageria only reflect differ- 
ent phenotypes of the same syndrome. 
This investigation corrobates a recent study de- 
scribing deficient decorin expression i  patients with 
infantile progeroid, so called Wiedemann- 
Rautenstrauch Syndrome and in a fibroblast strain 
obtained from a patient with Hutchinson-Guilford 
syndrome (progeria) [20]. However, in these 
progeroid-like fibroblasts normal collagen expression 
and overexpression f the small proteoglycan bigly- 
can was reported. In Marfan syndrome which has 
been shown to be a primary defect of fibrillin, de- 
creased extracellular deposition of fibrillin but also 
decorin has been described [21,22]. As it has been 
shown that the extracellular matrix can regulate the 
cellular behavior and the expression of several genes 
[13,23], the reduced ecorin biosynthesis observed in 
our patient might well be a secondary regulatory 
phenomenon, which is further supported by the nor- 
malization of decorin mRNA levels at higher passage 
numbers. 
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The nuclear un on data indicate that the reduced 
mRNA level of type I collagen is only partly at- 
tributable to a reduced transcription rate and may in 
addition be due to reduced mRNA stability. TGF-/3 
has previously been shown to enhance type I collagen 
expression both by increasing the transcription of the 
gene and transcript stability [24]. This corresponds 
well with the induction of mRNA steady-state l vels 
observed in this study. A physiological process where 
a marked presence of TGF-/3 has been described is 
wound healing [25]. Therefore the reversibility of the 
deficient collagen expression obtained after the incu- 
bation with TGF-/3 might well reflect the normal 
wound healing observed in this patient. 
In summary, this study further supports the notion 
that in acrogeria/metageria a deranged regulation of 
extracellular matrix production is involved in the 
altered skin and skeletal morphology of these pa- 
tients, as it has already been described for Werner's 
syndrome [26] and progeria [27]. Whether these bio- 
chemical alterations are primary or secondary phe- 
nomena in the pathophysiology of the premature 
aging syndromes, and which of these alterations in- 
deed reflect premature aging, remains to be deter- 
mined. 
References 
[1] Gilkes, J.J.H., Sharvill, D.E. and Wells, R.S. (1974) Br. J. 
Dermatol. 91,243-262. 
[2] Beauregard, S. and Gilchrest, B.A. (1987) Dermatol. Clin. 
5, 109-121. 
[3] Yu, C.-E., Oshima J., Fu Y.-H., et al. (1996) Science 272, 
258-262. 
[4] Hardingham, T.E. and Fosang, A.J. (1992) FASEB J. 6, 
861-870. 
[5] Ruoslahti, E. and Yamaguchi, Y. (1991) Cell 64, 867-869. 
[6] Kaufmann, I., Thiele, B. and Mahrle, G. (1984) Z. Hautkr. 
60, 975-984. 
[7] Fleischmajer, R., Perlish, J.S., Krieg, T. and Timpl, R. 
(1981) J. Invest. Dermatol. 76, 400-403. 
[8] Maniatis, T., Frisch, E.F. and Sambrook, J. (1982) Molecu- 
lar cloning. Cold Spring Harbor Laboratory, New York, 
1982, pp. 187-207. 
[9] Chu, M.L., Myers, J.C., Bernard, M.P., Ding, D.F. and 
Ramirez, F. (1982) Nucl. Acids Res. 10, 5925-5934. 
[10] Krusius, T. and Ruoslahti, E. (1986) Proc. Natl. Acad. Sci. 
USA 83, 7683-7687. 
[11] Brinker, J.M., Gudas L.J., Loidl, H.R., et al. (1985) Proc. 
Natl. Acad. Sci. USA 82, 3649-3653. 
[12] Bernard, M., Kolbe, M., Weil, D. and Chu, M.L. (1985) 
Biochemistry 24, 2698-2704. 
[13] Eckes, B., Mauch, C., Hiippe, G. and Krieg, T. (1993) 
FEBS Lett. 318, 129-133. 
[14] Marzluff, W.F. and Huang, R.C.C. (1993) Transcription of 
RNA in isolated nuclei. In Transcription and translation 
(Hames, B.D. and Higgins, S.J., eds.), pp. 89-130, IRL 
Press, Oxford. 
[15] Sykes, B., Puddle, B., Francis, M., Smith, R. (1976) 
Biochem. Biophys. Res. Commun. 72, 1472-1480. 
[16] Ignotz, R.A. and Massague, J. (1986) J. Biol. Chem. 261, 
4337-4345. 
[17] K~ih~iri, V.M., Larjava, H. and Uitto, J. (1991) J. Biol. 
Chem. 266, 10608-10615. 
[18] Greally, J.M., Boone, L.Y., Lenkey, S.G., Wenger, S.L. and 
Steele, M.W. (1992) Am. J. Med. Gen. 44, 334-339. 
[19] Bruckner Tuderman, L., Vogel, A. and Schnyder, U.W. 
(1987) Dermatologica 174, 157-165. 
[20] Beavan, L.A., Quentin-Hoffmann, E. Sch~3nherr, E. et al. 
(1993) J. Biol. Chem. 268, 9856-9862. 
[21] Pulkkinen, L., Kainulainen, K., Krusius, T., et al. (1990) J. 
Biol. Chem. 265, 17780-17785. 
[22] Ragunath, M., Superti-Furga, A., Godfrey, M, and Stein- 
mann, B. (1993)Hum. Genet. 90, 511-515. 
[23] Abelda, S.M. and Buck, S.A. (1990) FASEB J. 4, 2868- 
2880. 
[24] Penttinen, R.P., Kobayashi, S. and Bornstein, P. (1988) 
Proc. Natl. Acad. Sci. USA 85, 1105-1108. 
[25] Kane, C.J.M., Hebda, P.A., Mansbridge, J.N. and Hanawalt, 
P.C. (1991) J. Cell Physiol. 148, 157-173. 
[26] Hatamochi, A., Mori, K., Takeda, K., Arakawa, M., Ueki, 
H. and Yoshioka, H. (1993) J. Invest. Dermatol. 100, 771- 
774. 
[27] Colige, A., Roujeau, J.C., De la Roque, F., Nusgens B. and 
Lapiere, Ch.M. (1991) Lab. Invest. 64, 799-806 
